Table 1. Patient characteristics... | American Society of Hematology

Table 1.

Patient characteristics

Characteristic	Total cohort (n = 69)
Age in years∗	63 (34-70)
Male-to-female ratio	1.65
BM blast (%)∗	2 (0-7)
Hemoglobin (g/dL)∗	10 (8.6-10.9)
Absolute neutrophil counts (×10⁹/L)∗	1.1 (0.61-2.15)
Platelet counts (×10⁹/L)∗	47 (22-119)
Cytogenetics (%)
Deletion 7q/monosomy 7	44
Deletion 5q	3
Complex	6
Normal	16
Others	31
Treatments (%)†
HMA	28
HSCT	60
Both	12
IPSS-R categories (%)
Very low	6
Low	23
Intermediate	30
High	23
Very high	18
IPSS-M categories (%)
Very low	5
Low	19
Moderate low	14
Moderate high	14
High	29
Very high	19

Characteristic	Total cohort (n = 69)
Age in years∗	63 (34-70)
Male-to-female ratio	1.65
BM blast (%)∗	2 (0-7)
Hemoglobin (g/dL)∗	10 (8.6-10.9)
Absolute neutrophil counts (×10⁹/L)∗	1.1 (0.61-2.15)
Platelet counts (×10⁹/L)∗	47 (22-119)
Cytogenetics (%)
Deletion 7q/monosomy 7	44
Deletion 5q	3
Complex	6
Normal	16
Others	31
Treatments (%)†
HMA	28
HSCT	60
Both	12
IPSS-R categories (%)
Very low	6
Low	23
Intermediate	30
High	23
Very high	18
IPSS-M categories (%)
Very low	5
Low	19
Moderate low	14
Moderate high	14
High	29
Very high	19

HMA: hypomethylating agents; HSCT: hematopoietic stem cell transplant; IPSS-R: revised international prognostic scoring system.

Median (IQR).

Percentages are given on the proportion (48%) of treated cases.